Free Trial
CVE:VPT

VentriPoint Diagnostics (VPT) Stock Price, News & Analysis

VentriPoint Diagnostics logo
C$0.16
+0.01 (+3.33%)
(As of 11/4/2024 05:20 PM ET)

About VentriPoint Diagnostics Stock (CVE:VPT)

Key Stats

Today's Range
C$0.15
C$0.16
50-Day Range
C$0.15
C$0.20
52-Week Range
C$0.14
C$0.36
Volume
139,500 shs
Average Volume
98,820 shs
Market Capitalization
C$24.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

Receive VPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

VPT Stock News Headlines

VentriPoint Diagnostics (CVE:VPT) Shares Up 3.3% - Should You Buy?
Diagnostic Medical Sonographer Salary
Blackrock’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
VentriPoint Diagnostics Ltd (VPT)
See More Headlines

VPT Stock Analysis - Frequently Asked Questions

VentriPoint Diagnostics' stock was trading at C$0.30 at the start of the year. Since then, VPT shares have decreased by 47.5% and is now trading at C$0.16.
View the best growth stocks for 2024 here
.

Shares of VPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that VentriPoint Diagnostics investors own include Resverlogix (RVX), Meta Platforms (META), Sphere 3D (ANY), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), AuRico Gold Inc. Ordinary Share (AUQ) and Baytex Energy (BTE).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Net Income
C$-5,020,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$24,600.00
Cash Flow
C$0.03 per share
Book Value
C($0.01) per share

Miscellaneous

Free Float
N/A
Market Cap
C$24.36 million
Optionable
Not Optionable
Beta
0.39
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (CVE:VPT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners